主要文献
-
Chia, P.L., Ang, K. H., Thura, M., and Zeng, Q. (2023) PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types. Theranostics 13(6).
-
Thura, M., Sng, J. X. E., Ang, K. W., Li, J., Gupta, A., Hong, J. M., Hong, C. W., Zeng, Q. (2021) Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs. Biosci Rep 43 (9):BSR20211491.
-
Thura, M., Ye, Z., Al-Aidaroos, A.Q., Xiong, Q., Ong, J. Y., Gupta, A., Li, J., Guo, K., Ang, K. H., Zeng, Q. (2021) PRL3 induces Polypoid Giant Cancer Cells eliminated by PRL3-zumab to reduce tumor relapse. Communications Biology.
-
Thura, M., Al-Aidaroos, A.Q., and Zeng, Q. (2019) PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nature Communication 10:2484.
我们的首创新抗体抗癌药，为难治病人带来新希望。
联系我们
Top
